CX 2017 Presentations
Please note: Some presentations may not be available as permission may not have been given.
PERIPHERAL ARTERIAL CONSENSUS - Tuesday, 25th April
Venue: Upper Main Auditorium
PATHWAYS OF CARE
Intermittent claudication and lifestyle
Time: 08:00 - 08:41
| Chairing: | Iris Baumgartner, Bern, Switzerland |
| Moderator: | Frans Moll, Utrecht, Netherlands |
WHETHER to intervene
Time: 08:00 - 08:41
Time: 08:00 - 08:06
Tobacco cessation and arterial reconstruction
| Speaker: | Matthew Smeds, Little Rock, United States |
Time: 08:06 - 08:14
Supervised exercised therapy first - Netherlands 2009 - 2013
| Speaker: | David Hageman, Eindhoven, Netherlands |
CX DEBATE: Endovascular should be the first option rather than exercise
For the motion
| Michael Jaff, Boston, United States | |
| CLICK HERE TO VIEW VIDEO |
Against the motion
| Cliff Shearman, Southampton, United Kingdom | |
| CLICK HERE TO VIEW VIDEO |
Time: 08:26 - 08:41
Audience participation, discussion and polling
| Discussant: | Jacques Busquet, Paris St Cloud, France |
Acute and critical ischaemia consensus update
Time: 08:41 - 10:00
| Chairing: | Cliff Shearman, Southampton, United Kingdom |
| Moderator: | Iris Baumgartner, Bern, Switzerland |
Time: 08:41 - 08:47
The shift towards endovascular
| Speaker: | Martin Björck, Uppsala, Sweden |
Time: 08:47 - 08:53
Mechanical and thrombolytic value
| Speaker: | Frans Moll, Utrecht, Netherlands |
Time: 08:53 - 08:59
Novel diagnostic and therapeutic strategies for critical ischaemia
| Speaker: | Bijan Modarai, London, United Kingdom |
Superficial femoral artery
Time: 09:09 - 09:32
WHETHER to intervene and benefit from it
Time: 09:09 - 09:27
WHEN to intervene and at what threshold
Time: 09:09 - 09:27
INTERVENTION METHOD and outcomes as well as patency
Time: 09:09 - 09:15
Time: 09:09 - 09:15
Guidelines for superficial artery intervention
| Speaker: | Trevor Cleveland, Sheffield, United Kingdom |
Time: 09:15 - 09:21
Integrated approach to superficial femoral artery intervention
| Speaker: | Frank Vermassen, Ghent, Belgium |
Time: 09:21 - 09:32
Audience participation and discussion
Drug-coated balloon consensus update
Time: 09:32 - 10:00
Time: 09:32 - 09:38
Vessel preparation before drug-coated balloon use
| Speaker: | Thomas Zeller, Bad Krozingen, Germany |
Time: 09:38 - 09:44
The place of atherectomy and drug-coated balloon
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
Time: 09:44 - 09:50
Current guidelines for drug-coated balloon
| Speaker: | Michel Reijnen, Arnhem, Netherlands |
COFFEE
Time: 10:00 - 10:30
Industry Sponsored Satellite
Time: 10:00 - 10:30
Time: 10:00 - 10:30
ABBOTT - Branded Satellite with logo
Acute and critical ischaemia consensus update (continued)
Time: 10:30 - 12:30
| Chairing: | Roger Greenhalgh, London, United Kingdom |
| Moderator: | Trevor Cleveland, Sheffield, United Kingdom |
Drug-coated balloon consensus update (continued)
Time: 10:30 - 12:30
Time: 10:30 - 10:37
Podium 1st: 12-month outcomes of standard vs. wider usage of drug-coated balloon - IN.PACT global study
| Speaker: | Gary Ansel, Columbus, United States |
Time: 10:37 - 10:45
First-in-man: Randomised trial - DCB vs. PTA - 12-month data (RANGER-SFA)
| Speaker: | Dierk Scheinert, Leipzig, Germany |
Time: 10:45 - 10:52
Five-year results of laser and drug-coated balloon for in-stent restenosis
| Speaker: | Jos van den Berg, Lugano, Switzerland |
Time: 10:52 - 10:59
Podium 1st: Outcomes of drug-coated balloon with calcification, >15cm, complete total occlusion and TASC C and D lesions - IN.PACT study
| Speaker: | Fabrizio Fanelli, Florence, Italy |
Time: 11:13 - 11:20
Guidelines should reflect the latest clinical data
| Speaker: | Marianne Brodmann, Graz, Austria |
Time: 11:20 - 11:27
Evidence from ILLUMENATE European and US randomised controlled trials
| Speaker: | Prakash Krishnan, New York, United States |
Time: 11:27 - 11:34
Lutonix AV clinical trial results - DCB versus PTA for fistula access
| Speaker: | Scott Trerotola, Philadelphia, United States |
Time: 11:34 - 11:41
Head-to-head comparisons of drug-coated balloons
| Speaker: | Andrew Holden, Auckland, New Zealand |
Time: 11:41 - 11:46
Late breaking: Downstream coating effects of various DCBs
| Speaker: | Koen Deloose, Dendermonde, Belgium |
Time: 11:46 - 11:55
Audience participation, discussion and polling
| Discussant: | Giancarlo Biamino, Mercogliano, Italy |
Stent use consensus update
Time: 11:55 - 12:30
Time: 11:55 - 12:02
Primary SFA - stenting for claudication with 12 months' randomised controlled trial
| Speaker: | Hans I.V. Lindgren, Helsingborg, Sweden |
Time: 12:02 - 12:09
Swirling flow - producing better results in both primary stenting and in combination with DCB
| Speaker: | Peter Gaines, Sheffield, United Kingdom |
Time: 12:09 - 12:16
SUPERSUB - subintimal recanalisation in critical ischaemia trial
| Speaker: | Luis Mariano Palena, Abano Terme, Italy |
LUNCH
Time: 12:30 - 13:30
Industry Sponsored Satellite
Time: 12:30 - 13:00
Visit hands-on techniques
Time: 12:30 - 13:30
Stent use consensus update (continued)
Time: 13:30 - 14:47
| Chairing: | Thomas Zeller, Bad Krozingen, Germany |
| Moderator: | Barry Katzen, Miami, United States |
Time: 13:30 - 13:38
Beyond bare metal stent - the need for precision and durability in stents
| Speaker: | Fabien Thaveau, Strasbourg, France |
Time: 13:38 - 13:46
When a flexible stent is used with intravascular ultrasound
| Speaker: | Ian Spark, Kingswood, Australia |
Time: 13:46 - 13:54
Podium 1st: BIOFLEX PEACE - 12-month results on self-expanding flexible stent in femoropopliteal long lesions
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
The contribution of drug elution to a stent
Time: 14:04 - 14:47
Time: 14:04 - 14:12
Long-term results of drug-eluting stents have great significance
| Speaker: | Michael Dake, Tucson, United States |
Time: 14:12 - 14:20
Podium 1st: BIOLUX 4EVER - drug-coated balloon and stent in the SFA
| Speaker: | Koen Deloose, Dendermonde, Belgium |
Time: 14:20 - 14:28
Drug-eluting balloon vs. drug-coated stent (Real PTX)
| Speaker: | Dierk Scheinert, Leipzig, Germany |
Time: 14:28 - 14:36
DRASTICO - drug-eluting stent vs. drug-eluting balloon for TASC C and D lesions
| Speaker: | Francesco Liistro, Arezzo, Italy |
Popliteal aneurysm and angiosome concept
Time: 14:47 - 15:30
| Chairing: | Barry Katzen, Miami, United States |
| Moderator: | Thomas Zeller, Bad Krozingen, Germany |
INTERVENTION METHOD and outcomes
Time: 14:47 - 15:30
Time: 14:47 - 14:55
Risk factors for poor outcome after endovascular repair of politeal artery aneurysms
| Speaker: | Martin Björck, Uppsala, Sweden |
Time: 14:55 - 15:03
Long-term outcomes of stent graft for popliteal aneurysm
| Speaker: | Hervé Rousseau, Toulouse, France |
CX DEBATE: The angiosome concept is codswallop
For the motion
| Peter Gaines, Sheffield, United Kingdom | |
| CLICK HERE TO VIEW VIDEO |
Against the motion
| Maarit Venermo, Helsinki, Finland | |
| CLICK HERE TO VIEW VIDEO |
TEA
Time: 15:30 - 16:00
Industry Sponsored Satellite
Time: 15:30 - 16:00
Below the knee
Time: 16:00 - 17:05
| Chairing: | Iris Baumgartner, Bern, Switzerland |
| Moderator: | Frank Vermassen, Ghent, Belgium |
INTERVENTION METHOD and outcomes
Time: 16:00 - 17:05
Time: 16:00 - 16:09
"Endovascular first practice" may alter equipoise for below-the-knee trials
| Speaker: | Matthew Menard, Boston, United States |
Time: 16:09 - 16:18
Contrast-enhanced tomographic ultrasound (tUS) angiography of the peripheral arteries
| Speaker: | Charles McCollum, Manchester, United Kingdom |
Time: 16:18 - 16:27
Podium 1st: Latest drug-coated balloon outcomes from a BTK global registry
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
Time: 16:37 - 16:46
Differences following open and endovascular management of critical ischaemia using fluorescence imaging
| Speaker: | Maarit Venermo, Helsinki, Finland |
Time: 16:46 - 16:55
ABSORB study of a bioresorbable drug-eluting scaffold
| Speaker: | Ramon Varcoe, Randwick, Australia |
Diabetic foot consensus update
Time: 17:05 - 18:00
| Chairing: | Michael Edmonds, London, United Kingdom |
| Moderator: | Maarit Venermo, Helsinki, Finland |
Time: 17:05 - 17:14
Point-of-care duplex ultrasound - a paradigm shift in the detection of peripheral arterial disease in diabetes
| Speaker: | Pasha Normahani, Imperial College, London, UK |
Time: 17:14 - 17:23
Microvascular complications of diabetes and implications to cardiovascular risk
| Speaker: | Robert Hinchliffe, Bristol, United Kingdom |
Time: 17:23 - 17:32
A diabetic foot service in a department of vascular surgeons
| Speaker: | Dean Williams, Bangor, United Kingdom |
Time: 17:32 - 17:41
Measurement and improvement of wound healing in diabetics
| Speaker: | David Russell, Leeds, United Kingdom |
Time: 17:41 - 17:50
Delay designates disaster for diabetic foot
| Speaker: | Katariina Noronen, Helsinki, Finland |